Literatur
Centers for Disease Control and Prevention (2013) Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 – United States. MMWR Morb Mortal Wkly Rep 62(29):591–595
Berry DC, Knapp P, Raynor DK (2002) Provision of information about drug side-effects to patients. Lancet 359(9309): 853–854
o A (2013) Causality assessment of an adverse event following immunization (AEFI). ISBN: 978-92-4-150533-8. WHO reference number: WHO/HIS/EMP/QSS
Black S, Eskola J, Siegrist CA et al (2009) Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 374(9707):2115–2122
Siegrist CA, Lewis EM, Eskola J et al (2007) Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J 26(11):979–984
Vesikari T, Matson DO, Dennehy P et al (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354(1):23–33
Barlow WE, Davis RL, Glasser JW et al (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345:656–661
Sauvé LJ, Bettinger J, Scheifele D et al (2010) Postvaccination thrombocytopenia in Canada. Pediatr Inf Dis J 29(6):559–561
WHO (2002) WHO-Bulletin, Band. 80, Nr. 11
Lotte A, Wasz-Hockert O, Poisson N et al (1988) Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc 63(2):47–59
Bohlke K, Davis RL, Marcy SM (2003) Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112(4):815–820
Partinen M, Saarenpää-Heikkilä O, Ilveskoski I et al (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7(3):e33723
Nohynek H, Jokinen J, Partinen M et al (2012) AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7(3):e33536
Mutsch M et al (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 350:896–903
Paunio M, Heinonen OP, Virtanen M et al (2000) Measles history and atopic diseases: a population-based cross-sectional study. JAMA 283(3):343–346
Mrożek-Budzyn D, Kiełtyka A, Majewska R (2010) Lack of association between measles-mumps-rubella vaccination and autism in children. Pediatr Infect Dis J 29(5):397–400
Keller-Stanislawski B, Hartmann K (2001) Existiert ein Zusammenhang zwischen Impfungen und Typ-1-Diabetes mellitus bei Kindern und Jugendlichen? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 44(6):613–618
Ascherio A, Zhang SM, Hernán MA et al (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344:327–332
Einhaltung ethischer Richtlinien
Interessenkonflikt. I. Mutz hält Vorträge, die von Impffirmen gesponsert sind, und ist in Data Safety Monitoring Committees von Impfstoffstudien tätig.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Additional information
Nach einem Vortrag im Rahmen des 48. Pädiatrischen Fortbildungskurs in Obergurgl am 29.1.2015.
Rights and permissions
About this article
Cite this article
Mutz, I. Echte und vermeintliche Impfschäden. Paediatr. Paedolog. Austria 50, 57–62 (2015). https://doi.org/10.1007/s00608-015-0239-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00608-015-0239-6